• OPEN AN ACCOUNT
Indian Indices
Sensex
76,917.85 1,225.07
( 1.62%)
Global Indices
Nasdaq
52,165.19 373.88
(0.72%)
Dow Jones
7,596.72 -4.35
(-0.06%)
Hang Seng
63,112.86 -177.25
(-0.28%)
Nikkei 225
10,768.78 39.00
(0.36%)
Forex
USD-INR
94.93 -0.28
(-0.30%)
EUR-INR
105.90 -0.29
(-0.27%)
GBP-INR
127.09 0.08
(0.06%)
JPY-INR
0.60 0.00
(-0.15%)

EQUITY - MARKET SCREENER

CreditAccess Grameen Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
541770
INE741K01010
555.5225585
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CREDITACC
10.49
16642.83
EPS(TTM)
Face Value()
Div & Yield %
98.82
10
0
 

&hra cements ltd
Wanbury update on filing of DFM in US and South Korea
Jul 30,2026
Wanbury recently received “No DMF deficiency letter” from the office of USFDA (US Food and Drug Administration) for multiple ANDAs (Abbreviated New Drug Applications) with Metformin HCl API source of Wanbury for different formulations.

Further, Wanbury expanded business opportunities in South Korea for one more API by filing the DMF. Wanbury is committed for supply of best APIs to the new market for well-being of human being.